Soluble Urokinase-Type Plasminogen Activator Receptor and Arterial Stiffness in Patients with COPD

Lung
Renáta M BöcskeiAndrás Bikov

Abstract

Soluble urokinase-type plasminogen activator receptor (suPAR) is upregulated by inflammation and plays a role in the pathogenesis of atherosclerosis. Chronic obstructive pulmonary disease (COPD) is associated with enhanced systemic inflammation and increased risk for atherosclerosis, however, studies analysing the circulating suPAR levels in COPD are contradictory. The aim of the study was to investigate plasma suPAR concentrations together with markers of arterial stiffness in COPD. Twenty-four patients with COPD and 18 non-COPD, control subjects participated in the study. Plasma suPAR was measured, together with lung volumes, symptom burden, exacerbation history, markers of arterial stiffness and soluble inflammatory biomarkers, such as endothelin-1, high-sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6). Plasma suPAR levels were higher in COPD (2.84 ± 0.67 ng/ml vs. 2.41 ± 0.57 ng/ml, p = 0.03) and were related to lung function measured with FEV1 (r = - 0.65, p < 0.01) and symptom burden determined with the modified Medical Research Council questionnaire (r = 0.55, p < 0.05). Plasma suPAR concentrations correlated with various measures of arterial stiffness in all subjects, but only with ejection duration in COPD ...Continue Reading

References

Dec 4, 2002·Nature Reviews. Molecular Cell Biology·Francesco Blasi, Peter Carmeliet
Jun 19, 2004·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Martin B SteinsJoachim Kienast
Aug 2, 2005·The European Respiratory Journal·M R MillerUNKNOWN ATS/ERS Task Force
Jul 3, 2007·Journal of the American College of Cardiology·Michael F O'Rourke, Junichiro Hashimoto
Apr 10, 2009·JACC. Cardiovascular Imaging·Jun SugawaraHirofumi Tanaka
Nov 10, 2009·Behavior Research Methods·Franz FaulAlbert-Georg Lang
Oct 20, 2010·European Respiratory Review : an Official Journal of the European Respiratory Society·A BourdinN Roche
Mar 4, 2011·Journal of Internal Medicine·Jesper Eugen-Olsen
Nov 8, 2011·Respiratory Research·Jennifer A DickensUNKNOWN Evaluation of COPD Longitudinally to Identify Surrogate Endpoints (ECLIPSE) study investigators
Nov 16, 2011·Biomarker Insights·Anna GustafssonLennart Ljunggren
Dec 6, 2011·Atherosclerosis·Bianca Fuhrman
Jan 10, 2012·BMC Medicine·Katia DonadelloJean-Louis Vincent
Mar 31, 2012·International Journal of Cardiology·Stig LyngbækJørgen Jeppesen
May 25, 2012·PloS One·Alvar AgustíUNKNOWN Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators
Jun 4, 2013·Translational Research : the Journal of Laboratory and Clinical Medicine·Surya P Bhatt, Mark T Dransfield
Jun 25, 2013·Respiratory Medicine·Joy MillerUNKNOWN Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators
Nov 21, 2013·Stroke; a Journal of Cerebral Circulation·Margaretha PerssonGunnar Engström
Jan 17, 2014·The Lancet. Respiratory Medicine·Harvey O CoxsonUNKNOWN Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators
May 9, 2014·European Journal of Clinical Investigation·Shani BothaAletta E Schutte
Aug 16, 2014·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Ümmügülsüm CanŞebnem Yosunkaya
Feb 25, 2015·International Journal of Chronic Obstructive Pulmonary Disease·Aziz GumusUnal Sahin
Jun 30, 2015·The Canadian Journal of Cardiology·Gethin W HodgesJørgen L Jeppesen
Jan 23, 2016·European Journal of Clinical Investigation·Jesper Eugen-OlsenLars Tue Sørensen
Jan 1, 2015·Nature Reviews. Disease Primers·Peter J BarnesEmiel F M Wouters
Jun 9, 2017·Internal and Emergency Medicine·Pasquale AmbrosinoMatteo Nicola Dario Di Minno
Jun 15, 2017·Respiratory Research·Rachel L ZemansRussell P Bowler
Oct 3, 2017·European Journal of Internal Medicine·Frederik Fruergaard Larsen, J Asger Petersen
Nov 2, 2017·International Journal of Chronic Obstructive Pulmonary Disease·Izabela TuletaNadjib Schahab
Mar 15, 2018·Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia·Gehan Hassan AboEl-Magd, Maaly Mohamed Mabrouk

❮ Previous
Next ❯

Citations

Apr 21, 2020·International Journal of Chronic Obstructive Pulmonary Disease·Kjell E J HåkanssonLine J H Rasmussen
Dec 21, 2021·Frontiers in Immunology·Line Jee Hartmann RasmussenJesper Eugen-Olsen

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Software Mentioned

GraphPad Prism
GraphPad

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research
Ümmügülsüm CanŞebnem Yosunkaya
Liver International : Official Journal of the International Association for the Study of the Liver
Signe WieseSøren Møller
© 2022 Meta ULC. All rights reserved